TrialRheumatology (Oxford, England)2021

Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.

Nicolino Ruperto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.